fbpx

Immunotherapy Before Sarcoma Surgery Improves Outcomes By Dennis Thompson HealthDay Reporter

By   |  February 15, 2024

  • Immunotherapy can improve outcomes in patients undergoing surgery for soft-tissue sarcoma

  • Immunotherapy and radiation therapy prior to surgery led to 90% of patients having nearly all cancer cleared from their bodies

  • Overall five-year survival rates were 90% and 82% for two common forms of soft-tissue sarcoma

THURSDAY